FDA Approved: AMELUZ — Supplemental Application (Biofrontera Inc.)

View source ↗

Summary

FDA approved a supplemental application for AMELUZ (aminoLevulinic acid hydrochloride) from Biofrontera Inc., updating the labeling to reflect the approved use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• AMELUZ (AMINOLEVULINIC ACID HYDROCHLORIDE)

Snippet

SUPPL AP for AMELUZ (AMINOLEVULINIC ACID HYDROCHLORIDE)